Incidence of Eyelid Cancers in Taiwan. A 21-Year Review

Hsin Yi Lin, Ching Yu Cheng, Wen-Ming Hsu, W. H Linda Kao, Pesus Chou

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Purpose: To describe the epidemiologic characteristics and incidence trends of primary eyelid cancers in the Chinese population in Taiwan between 1979 and 1999. Design: Retrospective population-based cancer registry data review. Participants: A total of 1166 primary eyelid cancers coded to International Classification of Diseases 8 or 9, site 172.1 (malignant melanoma of eyelid) and 173.1 (other malignant neoplasm of eyelid) were retrieved from the Taiwan National Cancer Registry between January 1979 and December 1999. Of these, 1121 (96.1%) were histopathologically verified and were used for analysis. Methods: Age- and gender-specific incidence rates were calculated and were age-adjusted to the 2000 world standard population. Trends in incidence rates were estimated by calculating the annual percentage change. We further examined the effects of age, period of diagnosis, and birth cohort on incidence trends using age-period-cohort analysis. Main Outcome Measure: Age-standardized incidence rate. Results: The mean age at diagnosis of eyelid cancers was 62.6±14.1 years. The average annual age-standardized incidence rate was 3.2 per million during the study period. There was an overall increase of incidence rates from 1.5 per million in 1979 to 5.1 per million in 1999, with an annual percentage change of 4.63% (P<0.001). The most common eyelid malignancy was basal cell carcinoma (BCC; 65.1%), followed by squamous cell carcinoma (12.6%), and sebaceous cell carcinoma (7.9%). The increasing rates were mainly driven by an increase in the incidence of BCC. Cohort effects were found to play a major role in terms of model fit for the incidence trends of BCC. Conclusions: These national data reveal a rapidly increasing incidence of eyelid cancers from 1979 to 1999 in Taiwan. Basal cell carcinoma dominates the incidence trends, and the significant cohort effects give a warning of increasing risk of BCC in younger birth cohorts.

Original languageEnglish
Pages (from-to)2101-2107
Number of pages7
JournalOphthalmology
Volume113
Issue number11
DOIs
Publication statusPublished - Nov 1 2006
Externally publishedYes

Fingerprint

Eyelids
Taiwan
Incidence
Neoplasms
Cohort Effect
Basal Cell Carcinoma
Eyelid Neoplasms
Registries
Parturition
Population
International Classification of Diseases
Squamous Cell Carcinoma
Melanoma
Cohort Studies
Demography
Outcome Assessment (Health Care)
Carcinoma

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Lin, H. Y., Cheng, C. Y., Hsu, W-M., Kao, W. H. L., & Chou, P. (2006). Incidence of Eyelid Cancers in Taiwan. A 21-Year Review. Ophthalmology, 113(11), 2101-2107. https://doi.org/10.1016/j.ophtha.2006.06.001

Incidence of Eyelid Cancers in Taiwan. A 21-Year Review. / Lin, Hsin Yi; Cheng, Ching Yu; Hsu, Wen-Ming; Kao, W. H Linda; Chou, Pesus.

In: Ophthalmology, Vol. 113, No. 11, 01.11.2006, p. 2101-2107.

Research output: Contribution to journalArticle

Lin, HY, Cheng, CY, Hsu, W-M, Kao, WHL & Chou, P 2006, 'Incidence of Eyelid Cancers in Taiwan. A 21-Year Review', Ophthalmology, vol. 113, no. 11, pp. 2101-2107. https://doi.org/10.1016/j.ophtha.2006.06.001
Lin, Hsin Yi ; Cheng, Ching Yu ; Hsu, Wen-Ming ; Kao, W. H Linda ; Chou, Pesus. / Incidence of Eyelid Cancers in Taiwan. A 21-Year Review. In: Ophthalmology. 2006 ; Vol. 113, No. 11. pp. 2101-2107.
@article{174ca5ef4f6c4732910ae84d0b27b1ae,
title = "Incidence of Eyelid Cancers in Taiwan. A 21-Year Review",
abstract = "Purpose: To describe the epidemiologic characteristics and incidence trends of primary eyelid cancers in the Chinese population in Taiwan between 1979 and 1999. Design: Retrospective population-based cancer registry data review. Participants: A total of 1166 primary eyelid cancers coded to International Classification of Diseases 8 or 9, site 172.1 (malignant melanoma of eyelid) and 173.1 (other malignant neoplasm of eyelid) were retrieved from the Taiwan National Cancer Registry between January 1979 and December 1999. Of these, 1121 (96.1{\%}) were histopathologically verified and were used for analysis. Methods: Age- and gender-specific incidence rates were calculated and were age-adjusted to the 2000 world standard population. Trends in incidence rates were estimated by calculating the annual percentage change. We further examined the effects of age, period of diagnosis, and birth cohort on incidence trends using age-period-cohort analysis. Main Outcome Measure: Age-standardized incidence rate. Results: The mean age at diagnosis of eyelid cancers was 62.6±14.1 years. The average annual age-standardized incidence rate was 3.2 per million during the study period. There was an overall increase of incidence rates from 1.5 per million in 1979 to 5.1 per million in 1999, with an annual percentage change of 4.63{\%} (P<0.001). The most common eyelid malignancy was basal cell carcinoma (BCC; 65.1{\%}), followed by squamous cell carcinoma (12.6{\%}), and sebaceous cell carcinoma (7.9{\%}). The increasing rates were mainly driven by an increase in the incidence of BCC. Cohort effects were found to play a major role in terms of model fit for the incidence trends of BCC. Conclusions: These national data reveal a rapidly increasing incidence of eyelid cancers from 1979 to 1999 in Taiwan. Basal cell carcinoma dominates the incidence trends, and the significant cohort effects give a warning of increasing risk of BCC in younger birth cohorts.",
author = "Lin, {Hsin Yi} and Cheng, {Ching Yu} and Wen-Ming Hsu and Kao, {W. H Linda} and Pesus Chou",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.ophtha.2006.06.001",
language = "English",
volume = "113",
pages = "2101--2107",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Incidence of Eyelid Cancers in Taiwan. A 21-Year Review

AU - Lin, Hsin Yi

AU - Cheng, Ching Yu

AU - Hsu, Wen-Ming

AU - Kao, W. H Linda

AU - Chou, Pesus

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Purpose: To describe the epidemiologic characteristics and incidence trends of primary eyelid cancers in the Chinese population in Taiwan between 1979 and 1999. Design: Retrospective population-based cancer registry data review. Participants: A total of 1166 primary eyelid cancers coded to International Classification of Diseases 8 or 9, site 172.1 (malignant melanoma of eyelid) and 173.1 (other malignant neoplasm of eyelid) were retrieved from the Taiwan National Cancer Registry between January 1979 and December 1999. Of these, 1121 (96.1%) were histopathologically verified and were used for analysis. Methods: Age- and gender-specific incidence rates were calculated and were age-adjusted to the 2000 world standard population. Trends in incidence rates were estimated by calculating the annual percentage change. We further examined the effects of age, period of diagnosis, and birth cohort on incidence trends using age-period-cohort analysis. Main Outcome Measure: Age-standardized incidence rate. Results: The mean age at diagnosis of eyelid cancers was 62.6±14.1 years. The average annual age-standardized incidence rate was 3.2 per million during the study period. There was an overall increase of incidence rates from 1.5 per million in 1979 to 5.1 per million in 1999, with an annual percentage change of 4.63% (P<0.001). The most common eyelid malignancy was basal cell carcinoma (BCC; 65.1%), followed by squamous cell carcinoma (12.6%), and sebaceous cell carcinoma (7.9%). The increasing rates were mainly driven by an increase in the incidence of BCC. Cohort effects were found to play a major role in terms of model fit for the incidence trends of BCC. Conclusions: These national data reveal a rapidly increasing incidence of eyelid cancers from 1979 to 1999 in Taiwan. Basal cell carcinoma dominates the incidence trends, and the significant cohort effects give a warning of increasing risk of BCC in younger birth cohorts.

AB - Purpose: To describe the epidemiologic characteristics and incidence trends of primary eyelid cancers in the Chinese population in Taiwan between 1979 and 1999. Design: Retrospective population-based cancer registry data review. Participants: A total of 1166 primary eyelid cancers coded to International Classification of Diseases 8 or 9, site 172.1 (malignant melanoma of eyelid) and 173.1 (other malignant neoplasm of eyelid) were retrieved from the Taiwan National Cancer Registry between January 1979 and December 1999. Of these, 1121 (96.1%) were histopathologically verified and were used for analysis. Methods: Age- and gender-specific incidence rates were calculated and were age-adjusted to the 2000 world standard population. Trends in incidence rates were estimated by calculating the annual percentage change. We further examined the effects of age, period of diagnosis, and birth cohort on incidence trends using age-period-cohort analysis. Main Outcome Measure: Age-standardized incidence rate. Results: The mean age at diagnosis of eyelid cancers was 62.6±14.1 years. The average annual age-standardized incidence rate was 3.2 per million during the study period. There was an overall increase of incidence rates from 1.5 per million in 1979 to 5.1 per million in 1999, with an annual percentage change of 4.63% (P<0.001). The most common eyelid malignancy was basal cell carcinoma (BCC; 65.1%), followed by squamous cell carcinoma (12.6%), and sebaceous cell carcinoma (7.9%). The increasing rates were mainly driven by an increase in the incidence of BCC. Cohort effects were found to play a major role in terms of model fit for the incidence trends of BCC. Conclusions: These national data reveal a rapidly increasing incidence of eyelid cancers from 1979 to 1999 in Taiwan. Basal cell carcinoma dominates the incidence trends, and the significant cohort effects give a warning of increasing risk of BCC in younger birth cohorts.

UR - http://www.scopus.com/inward/record.url?scp=33750314861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750314861&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2006.06.001

DO - 10.1016/j.ophtha.2006.06.001

M3 - Article

VL - 113

SP - 2101

EP - 2107

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 11

ER -